Abstract
One reagent for two techniques: Compound [ 111In]1 provides a platform for sequential radionuclide and optical imaging of prostate cancer through targeting of the prostate-specific membrane antigen. Because the same subject can be dual-imaged after one injection of the agent, these findings support rapid clinical translation.
Original language | English (US) |
---|---|
Pages (from-to) | 9167-9170 |
Number of pages | 4 |
Journal | Angewandte Chemie - International Edition |
Volume | 50 |
Issue number | 39 |
DOIs | |
State | Published - Sep 19 2011 |
Keywords
- fluorescent probes
- imaging agents
- prostate cancer
- prostate-specific membrane antigen
- radiochemistry
ASJC Scopus subject areas
- Catalysis
- General Chemistry